Evidence map›Paper›PMID 41868990›Full record

ArticleAdvanced biomedical research2026

The Potential Anti Stress-like Properties of Escitalopram on Improvement of Spatial Memory in Rats Subjected to Predictable and Unpredictable Chronic Mild Stress.

Vajihe Saedi-Marghmaleki, Maryam Radahmadi, Hojjatallah Alaei, Hossein Khanahmad

Abstract read
In one paragraph

Article in Advanced biomedical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vajihe Saedi-MarghmalekiDepartment of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Maryam RadahmadiDepartment of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Hojjatallah AlaeiDepartment of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Hossein KhanahmadDepartment of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic stress and chronic escitalopram usage affect memory. This research examined the potential anti-stress-like properties of escitalopram in improving spatial memory in rats subjected to predictable and unpredictable chronic mild stress (PCMS and UCMS). Materials and Methods: A total of forty-nine male rats were assigned to various groups: control (Co), sham (Sh), predictable stress (P.St; 2 h daily/21 days), unpredictable stress (UP.St; 2 h daily/21 days), escitalopram (Esc; 10 mg/kg/day for 21 days), and stress groups with escitalopram (P.St-Esc and UP.St-Esc). The Barnes maze test evaluated spatial learning and memory across all groups. Subsequently, the hippocampal weight was measured. Results: Both the P.St and UP.St groups showed significant ( Conclusion: Both PCMS and UCMS adversely affected spatial learning and memory. Additionally, escitalopram improved spatial learning and memory only in rats subjected to PCMS conditions. Therefore, it seems that escitalopram improves learning and memory by different pathways in the PCMS and UCMS conditions. Consequently, it seems that different dosages of escitalopram are required to treat memory deficits due to various types of stress. Left hippocampal atrophy also confirmed the potential role of UCMS conditions in memory impairments.

Indexed as

Escitalopramhippocampusspatial learningspatial memorystress

Identifiers

PMID41868990
PMCPMC13004311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.